Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|HER2 Gene Mutation
Interventions: DRUG: Pyrotinib
Sponsor: Peking Union Medical College